Novo Nordisk
NVO
#15
Rank
HK$4.660 T
Marketcap
HK$1,051
Share price
2.14%
Change (1 day)
44.09%
Change (1 year)

Novo Nordisk A / S produces and markets pharmaceutical products and services. Since its founding in Denmark in 1923, the company has developed into a leading company in the diabetes sector worldwide.

Novo Nordisk (NVO) - Total assets

Total assets on the balance sheet as of June 2024 : HK$414.48 B

According to Novo Nordisk's latest financial reports the company's total assets are HK$414.48 B. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Novo Nordisk - Total assets on balance sheet (from 2001 to 2024)

Total assets by year

Year Total assets Change
2023-12-31HK$363.76 B34.01%
2022-12-31HK$271.45 B17.56%
2021-12-31HK$230.90 B24.32%
2020-12-31HK$185.74 B26.62%
2019-12-31HK$146.69 B10.38%
2018-12-31HK$132.89 B3.08%
2017-12-31HK$128.92 B20.38%
2016-12-31HK$107.09 B2.71%
2015-12-31HK$104.26 B6.77%
2014-12-31HK$97.65 B-3.3%
2013-12-31HK$100.98 B11.89%
2012-12-31HK$90.25 B3.1%
2011-12-31HK$87.54 B2.67%
2010-12-31HK$85.26 B4.26%
2009-12-31HK$81.77 B10.78%
2008-12-31HK$73.82 B1.13%
2007-12-31HK$73.00 B18.43%
2006-12-31HK$61.63 B19.84%
2005-12-31HK$51.43 B7.07%
2004-12-31HK$48.03 B6.08%
2003-12-31HK$45.28 B24.31%
2002-12-31HK$36.42 B9.13%
2001-12-31HK$33.38 B

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
HK$1.685 T 306.58%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$560.26 B 35.17%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$737.77 B 78.00%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$1.084 T 161.59%๐Ÿ‡ซ๐Ÿ‡ท France